Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer (Q44075876)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer |
scientific article |
Statements
1 reference
Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer (English)
1 reference
Motoyuki Yamashita
1 reference
Charles J Rosser
1 reference
Jain-Hua Zhou
1 reference
Xin-Qiao Zhang
1 reference
Robert J Connor
1 reference
Heidrun Engler
1 reference
Daniel C Maneval
1 reference
Takashi Karashima
1 reference
Bogdan A Czerniak
1 reference
Colin P N Dinney
1 reference
William F Benedict
1 reference
1 August 2002
1 reference
1 reference
9
1 reference
8
1 reference
687-691
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference